Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kylie Lepic"'
Autor:
Dennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic, Kristjan Paulson, David Allan, Ram Vasudevan Nampoothiri, Sylvie Lachance, Uday Deotare, Jennifer White, Mohamed Elemary, Kareem Jamani, Christina Fraga, Christopher Lemieux, Igor Novitzky-Basso, Arjun Datt Law, Rajat Kumar, Irwin Walker, Kirk R. Schultz
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1426-1444 (2024)
This is a consensus-based Canadian guideline whose primary purpose is to standardize and facilitate the management of chronic graft-versus-host disease (cGvHD) across the country. Creating uniform healthcare guidance in Canada is a challenge for a nu
Externí odkaz:
https://doaj.org/article/377e4a7e680a48e3b905fe5521e9a28c
Autor:
Stephanie A. Maier, Tobias Berg, Susan Berrigan, Jonathan Bramson, Chris Bredeson, Guy Cantin, Andrew Daly, Gwynivere A. Davies, Mahmoud Elsawy, Alejandro Garcia-Horton, Wilson Lam, Alix Lapworth, Kylie Lepic, Luciana Melo Garcia, Kirk R. Schultz, Ram Vasudevan Nampoothiri, Darrell White, Jean-Sébastien Delisle
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9970-10017 (2022)
On behalf of Cell Therapy Transplant Canada (CTTC), we are pleased to present the Abstracts of the CTTC 2022 Annual Conference. The conference was held in-person 15–18 June 2022, in Niagara Falls, Ontario. Poster authors presented their work during
Externí odkaz:
https://doaj.org/article/68ea8c1d5ffe42aa9ed762e1b2e8642a
Autor:
S. Lachance, Marcio M. Gomes, Jolanta Karpinski, Henrique Bittencourt, Mona Shafey, Gregory M.T. Guilcher, Nadia M. Bambace, Kylie Lepic
Publikováno v:
Transplantation and Cellular Therapy. 27:702-706
Hematopoietic stem cell transplantation (HSCT) and cellular therapy (CT) exploit the therapeutic potential of manipulated or unmanipulated hematopoietic cells to treat diseases. While initially dedicated to the treatment of hematologic malignancies a
Autor:
Joshua Xu, Dina Khalaf, Kylie Lepic, Hassan Zahreddine, Tobias Berg, Tom Kouroukis, Justin Lee, Irwin Walker, Brian Leber, Parveen Wasi, Tony Chen, Christopher M. Hillis
Publikováno v:
Blood. 138:3379-3379
Background: AML is a complex disease that encompasses a huge variation of cytogenetic and mutational backgrounds, which is often complicated by age related functional deficits (Klepin et al. 2013). Given the expanding availability of reduced-intensit
Publikováno v:
Human Immunology. 80:45
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S121-S122
Introduction Timely access to transplantation for patients with acute myeloid leukemia avoids bridging chemotherapy and associated toxicity, avoids early relapse, and minimizes resource utilization. Evidence indicates that consolidation chemotherapy
Publikováno v:
Human Immunology. 79:72
Syngeneic transplants provide an interesting dilemma with respect to donor selection. The risk of relapse is higher for patients with AML undergoing syngeneic transplant vs. HLA-matched sibling transplant, however, rates of graft versus host disease
Publikováno v:
Human Immunology. 79:98
The clinical significance of HLA-DP donor specific antibodies (DSA) detected with solid phase assays in recipients of renal transplants remains poorly defined. Recent literature has elucidated that many patients have a HLA-DP antibody pattern of reac
Autor:
Teri-Lynn Steeves, Kylie Lepic, Evangelos Petropoulos, Christine Ribic, Michelle Watson, Waliul I. Khan, Bruce Young
Publikováno v:
Human Immunology. 79:120
Aim Spondyloarthropathies are more commonly diagnosed in patients that are positive for HLA B27. The Immunology lab in Hamilton Regional Laboratory Medicine Program (HRLMP) currently performs 200 samples/week of HLA B27 Immunophenotyping test by conv
Publikováno v:
Human Immunology. 78:227
Mixed chimerism refers to the presence of DNA from 2 different individuals in a patient’s peripheral blood and can present interesting challenges when HLA typing. We present 2 examples of patients with mixed chimerism and the steps taken to confirm